KLK3 and posterior cortical atrophy: Increased availability and use of PSA testing as a screening tool has led to an increase in the incidence of low and intermediate risk disease as well as stage migration in PCa across a number of countries [4], with a large proportion of PSA-detected cancers classified as low-grade/low-volume indolent disease, with little metastatic potential [5].